FR2634377B1 - Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif - Google Patents
Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actifInfo
- Publication number
- FR2634377B1 FR2634377B1 FR8809046A FR8809046A FR2634377B1 FR 2634377 B1 FR2634377 B1 FR 2634377B1 FR 8809046 A FR8809046 A FR 8809046A FR 8809046 A FR8809046 A FR 8809046A FR 2634377 B1 FR2634377 B1 FR 2634377B1
- Authority
- FR
- France
- Prior art keywords
- extended release
- release pharmaceutical
- pharmaceutical form
- form based
- active resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8809046A FR2634377B1 (fr) | 1988-06-30 | 1988-06-30 | Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif |
EP89450008A EP0349453A1 (fr) | 1988-06-30 | 1989-04-21 | Nouvelle forme pharmaceutique à libération prolongée à base d'un complexe résine-principe actif |
PT91003A PT91003A (pt) | 1988-06-30 | 1989-06-28 | Processo para a preparacao de uma nova forma farmaceutica de libertacao prolongada a base de um complexo de resina-principio activo |
ES8902279A ES2016033A6 (es) | 1988-06-30 | 1989-06-28 | Procedimiento de obtencion de una nueva forma farmaceutica de libeeracion prolongada basada en un complejo resina-principio activo. |
MA21835A MA21586A1 (fr) | 1988-06-30 | 1989-06-29 | Procede de preparition d'une nouvelle forme pharmaceutique a liberation prolongee comprenant un complexe resine principe actif. |
ZA896286A ZA896286B (en) | 1988-06-30 | 1989-08-17 | New extended release pharmaceutical form based on a resin/active principle complex |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8809046A FR2634377B1 (fr) | 1988-06-30 | 1988-06-30 | Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2634377A1 FR2634377A1 (fr) | 1990-01-26 |
FR2634377B1 true FR2634377B1 (fr) | 1991-09-27 |
Family
ID=9368055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8809046A Expired - Fee Related FR2634377B1 (fr) | 1988-06-30 | 1988-06-30 | Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0349453A1 (fr) |
ES (1) | ES2016033A6 (fr) |
FR (1) | FR2634377B1 (fr) |
MA (1) | MA21586A1 (fr) |
PT (1) | PT91003A (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7906145B2 (en) | 2002-04-09 | 2011-03-15 | Flamel Technologies | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
US7910133B2 (en) | 2002-04-09 | 2011-03-22 | Flamel Technologies | Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9015822D0 (en) * | 1990-07-18 | 1990-09-05 | Beecham Group Plc | Compositions |
HUT74642A (en) * | 1990-12-21 | 1997-01-28 | Richardson Vicks Inc | Polyamine drug-resin complex |
US5275820A (en) * | 1990-12-27 | 1994-01-04 | Allergan, Inc. | Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles |
CA2178620A1 (fr) * | 1993-12-08 | 1995-06-15 | Lisa B. Jungherr | Systeme de liberation de medicament a microbilles |
ES2097087B1 (es) * | 1994-08-01 | 1997-12-16 | Univ Sevilla | Sistema de liberacion controlada de morfina y otros farmacos solubles en agua por complejacion con sustancias polimericas. |
US7854924B2 (en) | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
PL1732523T3 (pl) | 2004-03-30 | 2010-08-31 | Vifor Pharma Tech Ltd | Polimery wiążące potas i ich zastosowania |
US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
US7556799B2 (en) | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
US7429394B2 (en) | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
US8192758B2 (en) | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
PT3219312T (pt) * | 2004-03-30 | 2019-03-01 | Relypsa Inc | Polímeros de ligação a ião e seus usos |
US8586097B2 (en) | 2005-09-30 | 2013-11-19 | Relypsa, Inc. | Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
US8617609B2 (en) | 2005-09-30 | 2013-12-31 | Relypsa, Inc. | Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
BR112015007749A2 (pt) | 2012-10-08 | 2017-07-04 | Relypsa Inc | métodos para tratamento de hipertensão , de hipercaliemia , e de doença renal crônica. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2246037B2 (de) * | 1972-09-20 | 1975-02-27 | Taeschner & Co, 8831 Kipfenberg | Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform |
-
1988
- 1988-06-30 FR FR8809046A patent/FR2634377B1/fr not_active Expired - Fee Related
-
1989
- 1989-04-21 EP EP89450008A patent/EP0349453A1/fr not_active Withdrawn
- 1989-06-28 ES ES8902279A patent/ES2016033A6/es not_active Expired - Fee Related
- 1989-06-28 PT PT91003A patent/PT91003A/pt unknown
- 1989-06-29 MA MA21835A patent/MA21586A1/fr unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
US7906145B2 (en) | 2002-04-09 | 2011-03-15 | Flamel Technologies | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
US7910133B2 (en) | 2002-04-09 | 2011-03-22 | Flamel Technologies | Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
Also Published As
Publication number | Publication date |
---|---|
FR2634377A1 (fr) | 1990-01-26 |
EP0349453A1 (fr) | 1990-01-03 |
MA21586A1 (fr) | 1990-04-01 |
ES2016033A6 (es) | 1990-10-01 |
PT91003A (pt) | 1989-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2634377B1 (fr) | Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif | |
FR2624732B1 (fr) | Formulation pharmaceutique a liberation prolongee | |
IT8603467A0 (it) | Farmaci ad attivita'antiflogistica nuove formulazioni galeniche a cessione programmata contenenti | |
FR2598148B1 (fr) | Formulations a base d'amidon. | |
FR2664163B1 (fr) | Forme posologique pharmaceutique solide orale a liberation programmee. | |
FR2518409B1 (fr) | Preparations therapeutiques a liberation prolongee a base d'hydroxypropylmethylcellulose | |
IT8948369A0 (it) | Composizioni farmaceutiche a base di ciclosporine | |
FR2642650B1 (fr) | Nouvelles compositions pharmaceutiques a base de cyclosporines | |
FR2643263B1 (fr) | Composition pharmaceutique a base de ranitidine | |
FR2600253B1 (fr) | Nouvelles compositions pharmaceutiques a base de ketotifene | |
FR2614790B1 (fr) | Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique | |
FR2604902B1 (fr) | Compositions pharmaceutiques a liberation prolongee | |
FR2634125B1 (fr) | Composition pharmaceutique a base de superoxyde dismutase | |
FR2661830B1 (fr) | Nouvelle compositions pharmaceutiques a base de flavonoside. | |
IT1229231B (it) | Aminoimidazopiridine farmacologicamente attive | |
GB2246072B (en) | Solid pharmaceutical compositions containing a light sensitive active ingred ient and stabilised by a dye | |
FI914436A0 (fi) | Foerfarande foer framstaellning av baktericida matriser. | |
FR2589732B1 (fr) | Nouvelle formulation a liberation prolongee a base de pindolol | |
FR2521997B1 (fr) | Nouvelle association medicamenteuse a base de morniflumate | |
MC2109A1 (fr) | Dérivés d'acides aminés | |
FR2605885B1 (fr) | Association medicamenteuse a base d'un inhibiteur calcique | |
FR2594334B1 (fr) | Composition pharmaceutique injectable a base d'amoxicilline | |
OA09301A (fr) | "Nouvelle forme galénique orale améliorant la biodisponibilité". | |
IT1222698B (it) | Composti a base di 7-ossabiciclo (2.2.1) eptano aventi attivita' farmaceutica | |
PT100896A (pt) | Composicao farmaceutica para a neutralizacao da interleuquina-1(il-1) utilizando dsrna's |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |